InvestorsHub Logo
Followers 2133
Posts 93289
Boards Moderated 0
Alias Born 12/17/2011

Re: None

Friday, 07/31/2020 8:51:08 AM

Friday, July 31, 2020 8:51:08 AM

Post# of 1121
ACST...64...Bullish Harami Cross as the Bollies start to squeeze...

Chart...http://schrts.co/icRCzmMn

LAVAL, Québec, July 31, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (sHTG) (triglyceride blood levels from 500 mg/dL to 1500 mg/dL), today announced it has completed its revisions to the pre-specified Statistical Analysis Plan (SAP) for the TRILOGY 2 Phase 3 trial of CaPre, and has filed it with the Food and Drug Administration (FDA).

https://www.otcmarkets.com/stock/ACST/news/story?e&id=1658648

Its is not about how much profit you make on a trade but how many profitable trades you are able to make...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACST News